Cargando…

Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia

Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Whyte, Martin, Quaglia, Alberto, Hopkins, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/
https://www.ncbi.nlm.nih.gov/pubmed/26783443
http://dx.doi.org/10.1002/ccr3.458
_version_ 1782409158870433792
author Whyte, Martin
Quaglia, Alberto
Hopkins, David
author_facet Whyte, Martin
Quaglia, Alberto
Hopkins, David
author_sort Whyte, Martin
collection PubMed
description Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affect how such patients are managed with insulin.
format Online
Article
Text
id pubmed-4706392
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47063922016-01-18 Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia Whyte, Martin Quaglia, Alberto Hopkins, David Clin Case Rep Case Reports Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affect how such patients are managed with insulin. John Wiley and Sons Inc. 2015-12-01 /pmc/articles/PMC4706392/ /pubmed/26783443 http://dx.doi.org/10.1002/ccr3.458 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Whyte, Martin
Quaglia, Alberto
Hopkins, David
Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title_full Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title_fullStr Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title_full_unstemmed Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title_short Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
title_sort insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/
https://www.ncbi.nlm.nih.gov/pubmed/26783443
http://dx.doi.org/10.1002/ccr3.458
work_keys_str_mv AT whytemartin insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia
AT quagliaalberto insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia
AT hopkinsdavid insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia